The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer

Cell Death & Disease, Published online: 26 January 2021; doi:10.1038/s41419-021-03414-3The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer

http://feeds.nature.com/~r/cddis/rss/current/~3/ooXjXFiSa1s/s41419-021-03414-3

Source: Cell death and disease - January 26, 2021 Category: Internal Medicine Authors: Christopher E. Eyermann John D. Haley Evguenia M. Alexandrova Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Internal Medicine